Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Common Stock | Options Exercise | $82.3K | +10K | +6.27% | $8.23 | 170K | Mar 1, 2022 | Direct | |
transaction | PLAB | Common Stock | Sale | -$174K | -9.7K | -5.72% | $17.94 | 160K | Mar 1, 2022 | Direct | F1, F2, F3 |
transaction | PLAB | Common Stock | Sale | -$5.59K | -300 | -0.19% | $18.63 | 160K | Mar 1, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Non-Qualified Stock Options | Options Exercise | $0 | -10K | -46.55% | $0.00 | 11.5K | Mar 1, 2022 | Common Stock | 10K | $8.23 | Direct |
Id | Content |
---|---|
F1 | The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Progler. |
F2 | Net proceeds of sale to fund children's education. |
F3 | This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |